Prenatal Intravenous Magnesium at 30-34 Weeks’ Gestation and Neurodevelopmental Outcomes in Offspring

Overview of attention for article published in JAMA: Journal of the American Medical Association, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 22 news outlets
blogs: 6 blogs
twitter: 152 X users

facebook: 1 Facebook page
guideline: 1 clinical guideline source
podcasts: 4 podcasts

Readers on

mendeley: 97 Mendeley

So far, Altmetric has seen 23 news stories from 22 outlets.

Magnesium Sulfate Reduces Cerebral Palsy in Preterm Birth

Medscape, 25 Jun 2024

An updated Cochrane Systematic Review of magnesium sulfate administered before preterm birth for neuroprotection has reaffirmed…

Magnesium Sulfate’s Ability to Reduce Cerebral Palsy in Preterm Birth Reaffirmed

Pediatric News , 21 Jun 2024

An updated Cochrane Systematic Review of magnesium sulfate administered before preterm birth for neuroprotection has reaffirmed…

Prenatal magnesium at 30-34 weeks does not reduce risk of death or cerebral palsy: MAGENTA trial | 2 Minute Medicine

2 Minute Medicine , 15 Sep 2023

1. Efficacy: There was no significant difference in death or cerebral palsy at 2 years between those who received magnesium…

Frühgeburt: Kein Schutz vor Zerebralparese durch Magnesium in SSW 30-34

Deutsches Ärzteblatt, 30 Aug 2023

Medizin Mittwoch, 30. August 2023 Auckland – Bei einer Frühgeburt in der Schwangerschaftswoche (SSW) 30-34 reduziert die…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 19 additional news stories.